EUVIMEDEUVIMED entdecken
Open Access

Theranostics for Neuroblastoma: Making Molecular Radiotherapy Work Better

Peter J Gawne, Helen E Bryant, Steven G DuBois, Sally L George, Juliet Gray, Leona Knox, Kyle B Matchett, Connie Peet, Katherine A Vallis, Hugh J Wallace, Simon Wan, Mark N Gaze

Journal of Nuclear Medicine · 2025-04 · 66 (4) · 490-496

DOI: 10.2967/jnumed.124.269121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nuclear Medicine, online erschienen am 20.02.2025. Verfasst von Peter J Gawne und 11 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary, University of London, London, United Kingdom. Hauptthemen laut MEDLINE: Neuroblastoma, Theranostic Nanomedicine. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Cancer Research UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeuroblastomaTheranostic NanomedicineHumans3-Iodobenzylguanidine

Stichwörter der Autor:innen

molecular radiotherapyneuroblastomaradionuclide therapyradiopharmaceutical therapytheranostics

Substanzen

3-Iodobenzylguanidine

Autor:innen und Institutionen

  • Centre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary, University of London, London, United Kingdom.
  • UCL Cancer Institute, University College London, London, United Kingdom.
  • School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom.
  • School of Medicine and Population Health, University of Sheffield, Sheffield, United Kingdom.
  • Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts.
  • Division of Clinical Studies, Institute of Cancer Research, London, United Kingdom.

Förderung

  • Cancer Research UK

Zitieren

APA

Gawne, P. J., Bryant, H. E., DuBois, S. G., George, S. L., Gray, J., Knox, L., Matchett, K. B., Peet, C., Vallis, K. A., Wallace, H. J., Wan, S., & Gaze, M. N. (2025). Theranostics for Neuroblastoma: Making Molecular Radiotherapy Work Better. Journal of Nuclear Medicine, 66(4), 490-496. https://doi.org/10.2967/jnumed.124.269121

Vancouver

Gawne PJ, Bryant HE, DuBois SG, George SL, Gray J, Knox L, et al. Theranostics for Neuroblastoma: Making Molecular Radiotherapy Work Better. Journal of Nuclear Medicine. 2025;66(4):490-496. doi:10.2967/jnumed.124.269121

BibTeX
@article{Gawne2025,
  author = {Gawne, Peter J and Bryant, Helen E and DuBois, Steven G and George, Sally L and Gray, Juliet and Knox, Leona and Matchett, Kyle B and Peet, Connie and Vallis, Katherine A and Wallace, Hugh J and Wan, Simon and Gaze, Mark N},
  title = {Theranostics for Neuroblastoma: Making Molecular Radiotherapy Work Better},
  journal = {Journal of Nuclear Medicine},
  year = {2025},
  volume = {66},
  number = {4},
  pages = {490--496},
  doi = {10.2967/jnumed.124.269121}
}
Kostenlos starten →